Role of Formoterol and Budesonide inhaler in childhood asthma
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: J452- Mild intermittent asthmaHealth Condition 2: J453- Mild persistent asthmaHealth Condition 3: J454- Moderate persistent asthmaHealth Condition 4: J459- Other and unspecified asthmaHealth Condition 5: J455- Severe persistent asthma
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Children aged 6-18 years
2. Bronchial asthma requiring treatment as per GINA guidelines step 1 to 4
3. Ability to perform spirometry in accordance with the standards of the American
Thoracic Society
Exclusion Criteria
1. Co-existent other chronic pulmonary diseases
2. Chronic renal, gastrointestinal diseases, hepatic or cardiac diseases
3. History of active smoking
4. Patient who took a systemic corticosteroid within the previous 4 weeks
5. Prior PICU admission for asthma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the proportion of children with asthma showing improved asthma control questionnaire(ACQ) score between the two groupsTimepoint: 12 weeks and 24 weeks
- Secondary Outcome Measures
Name Time Method To compare the improvement in level of control of asthma, number and severity of exacerbations and <br/ ><br>time to first exacerbation on treatment in both groupsTimepoint: 24 weeks;To compare the proportion of children showing improved Pediatric Asthma Quality of life score(PAQLQ) between the two groupsTimepoint: 24 weeks;To compare the proportion of children with improved spirometric parameters between the two groupsTimepoint: 24 weeks